Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1504 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
ImCheck Pharmaceuticals S.A.S.. (5/2/17). "Press Release: ImCheck Therapeutics Raises €20 Million and Appoints its CEO". Marseille. 2017-05-02
Abivax S.A.. (5/2/17). "Press Release: First Ever Evidence of Treatment-induced Reduction in HIV Reservoirs". Paris. 2017-05-02
Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg. 2017-04-28
Hybrigenics S.A.. (4/28/17). "Press Release: Hybrigenics Full Year 2016 Results". Paris. 2017-04-28
Sartorius AG. (4/28/17). "Press Release: Sartorius Stedim Biotech Introduces New BIOSTAT STR Bioreactor Range". Göttingen & Aubagne. 2017-04-28
Novacyt S.A.. (4/27/17). "Press Release: Novacyt Full Year 2016 Results". Paris & Cambridge. 2017-04-27
Genkyotex S.A.. (4/27/17). "Press Release: Genkyotex Provides Business Update for Q1 2017. Cash & Cash Equivalents of €21.8 million as of March 31, 2017". Toulouse & Geneva. 2017-04-27
Poxel S.A.. (4/25/17). "Press Release: Poxel Announces Appointment of Anne Renevot as Chief Financial Officer". Lyon. 2017-04-25
Transgene S.A.. (4/25/17). "Press Release: Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer". New York, NY & Stras 2017-04-25
Transgene S.A.. (4/24/17). "Press Release: SillaJen and Transgene Announce the Enrollment of the First European Patient in Multinational Phase 3 Trial for Pexa-Vec in Advanced Liver Cancer". Seoul, San Francisco, CA & Strasbourg. 2017-04-24
Lysogene S.A.. (4/21/17). "Press Release: 2016 Annual Results". Paris & Cambridge, MA. 2017-04-21
IntegraGen S.A.. (4/21/17). "Press Release: IntegraGen Announces 2016 Annual Results". Évry. 2017-04-21
bioMérieux S.A.. (4/20/17). "Press Release: bioMérieux – First-Quarter 2017 Business Review". Marcy l’Étoile. 2017-04-20
Advent France Biotechnology S.A.S.. (4/20/17). "Press Release: Advent France Biotechnology Announces Its First Life Sciences Dedicated Seed-Fund with a First Closing at €64.75M (USD68.5M)". Paris. 2017-04-20
bioMérieux S.A.. (4/20/17). "Press Release: The FilmArray Respiratory Panel 2 plus (RP2plus) Gets CE marked". Marcy l’Étoile. 2017-04-20
Lysogene S.A.. (4/20/17). "Press Release: Lysogene Announces Selection of MRI Interventions’ SmartFlow Cannula for Phase II/III Clinical Study in MPS IIIA". Paris & Cambridge, MA. 2017-04-20
Transgene S.A.. (4/19/17). "Press Release: Marie Landel and Maya Said Nominated to be Independent Members of Transgene’s Board of Directors". Strasbourg. 2017-04-19
Erytech Pharma. (4/13/17). "Press Release: Erytech to Raise €70.5 Million in a Private Placement to U.S. and European Investors [Not for United States, Australia, Canada or Japan]". 2017-04-13
Transgene S.A.. (4/12/17). "Press Release: Transgene and Institut Bergonié Start the Phase 2 Part of the METROmaJX Trial". Strasbourg. 2017-04-12
Erytech Pharma. (4/12/17). "Press Release: Erytech Launches Capital Increase by Means of a Private Placement [Not for United States, Australia, Canada or Japan]". 2017-04-12
Cellectis S.A.. (4/12/17). "Press Release: Cellectis S.A. to Explore Possible Initial Public Offering of Calyxt, Inc.". 2017-04-12
Transgene S.A.. (4/10/17). "Press Release: Transgene Announces Upcoming Investor Meetings and R&D Day". Strasbourg. 2017-04-10
Nanobiotix S.A.. (4/6/17). "Press Release: Nanobiotix Launches Capital Increase by Means of an Accelerated Bookbuild Offering [Not for United States, Canada, Australia or Japan]". Paris & Cambridge, MA. 2017-04-06
Novacyt S.A.. (4/6/17). "Press Release: Novacyt Announces Bond Issue". Paris & Cambridge. 2017-04-06
Nanobiotix S.A.. (4/6/17). "Press Release: Nanobiotix Successfully Completes approx. EUR 25.1 Million Private Placement of New Shares [Not for United States, Canada, Australia or Japan]". Paris & Cambridge, MA. 2017-04-06
bioMérieux S.A.. (4/6/17). "Press Release: bioMérieux Receives FDA 510(k) Clearance for its BacT/Alert VIRTUO Fully Automated Blood Culture System". Marcy l’Étoile. 2017-04-06
Nanobiotix S.A.. (4/4/17). "Press Release: Nanobiotix Expands Its Clinical Development in Head and Neck Cancer and Immuno-oncology. New Clinical Data to Be Presented at ASCO". Paris & Cambridge, MA. 2017-04-04
Cellnovo. (4/3/17). "Press Release: Cellnovo Appoints Erwan Martin as Chief Financial Officer". Paris. 2017-04-03
AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-31
Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris. 2017-03-30
Nosopharm S.A.S.. (3/28/17). "Press Release: Nosopharm Raises €2.4 million ($2.6m) to Develop a novel Antibiotic Class". Lyon. 2017-03-28
Sofinnova Partners. (3/28/17). "Press Release: Antoine Papiernik Appointed Chairman of Sofinnova Partners". Paris. 2017-03-28
AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-27
Erytech Pharma. (3/27/17). "Press Release: Erytech Reports Positive Phase 2b Data for Eryaspase for the Treatment of Metastatic Pancreatic Cancer". Lyon. 2017-03-27
Eurofins Scientific. (3/21/17). "Press Release: Eurofins and USP Announce Collaboration to Tackle Food Fraud". 2017-03-21
Symetis AG. (3/20/17). "Press Release: Symetis Launches Its IPO on Euronext Paris [This document may not be released, published or distributed, directly or indirectly, in or into Australia, Canada, Japan or the United States]". 2017-03-20
Advicenne S.A.. (3/20/17). "Press Release: Advicenne Announces the Closing of a €16 Million Financing Round". Nîmes. 2017-03-20
DBV Technologies S.A.. (3/15/17). "Press Release: DBV Technologies Reports Full Year 2016 Financial Results". 2017-03-15
Hybrigenics S.A.. (3/13/17). "Press Release: Strategic Refocusing on Biopharmaceutical R&D". Paris. 2017-03-13
DBV Technologies S.A.. (3/10/17). "Press Release: DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children". 2017-03-10
Servier. (3/9/17). "Press Release: Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia". 2017-03-09
TxCell S.A.. (3/9/17). "Press Release: TxCell 2016 Financial Results". Valbonne. 2017-03-09
Pharnext S.A.. (3/9/17). "Press Release: Pharnext Announces R&D Agreement with Galapagos to Generate a New Pipeline of Synergistic Drug Combinations". Paris. 2017-03-09
Nicox S.A.. (3/9/17). "Press Release: Nicox Resubmits AC-170 (Zerivate) NDA to the U.S. FDA". Sophia Antipolis. 2017-03-09
IntegraGen S.A.. (3/8/17). "Press Release: Laboratoire Cerba Enters into Licensing Agreement with IntegraGen for the Commercialization of miR-31-3p Tumor Expression Test in France, Benelux, Middle East and Africa". Saint-Ouen l’Aumône & Évry. 2017-03-08
Novasep S.A.. (3/7/17). "Press Release: Novasep Appoints Xavier de Saint Guilhem as Chief Financial Officer". Lyon. 2017-03-07
Servier. (3/6/17). "Press Release: Vernalis plc and Servier Enter into a New Drug Discovery Collaboration Strengthening Their Existing Partnership". 2017-03-06
Pierre Fabre S.A.. (3/3/17). "Press Release: Pierre Fabre and Hill Dermaceuticals, Inc. Announce a Strategic Commercial Partnership for Tolak® (fluorouracil) Cream 4% in the USA and Beyond". Lavaur & Sanford, FL. 2017-03-03
bioMérieux S.A.. (3/3/17). "Press Release: 2016 Financial Results". 2017-03-03
Sofinnova Partners. (3/2/17). "Press Release: Sofinnova Partners Raises €106 million in a First Closing of Its Industrial Biotech Fund". Paris. 2017-03-02
Nicox S.A.. (3/1/17). "Press Release: Nicox to Participate at Two Upcoming Investor Conferences". Sophia Antipolis. 2017-03-01
Cerenis Therapeutics S.A.. (3/1/17). "Press Release: Cerenis Therapeutics Announces Top Line Results of CARAT Phase II Study. No Statistical Difference Observed between CER-001 and Placebo". Toulouse & Ann Arbor, MI. 2017-03-01
Genticel S.A.. (2/28/17). "Press Release: Genticel becomes “Genkyotex”. Genticel’s General Meeting Approves the Strategic Combination with GenKyoTex SA [Not for Australia, Canada, Japan, New Zealand, South Africa or the United States]". Toulouse & Geneva 2017-02-28
Genticel S.A.. (2/28/17). "Press Release: Genticel Announces Its 2016 Annual Results". Paris & Toulouse. 2017-02-28
Sanofi S.A.. (2/27/17). "Press Release: Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility". Paris & Basel. 2017-02-27
bioMérieux S.A.. (2/24/17). "Press Release: bioMérieux’s VIDAS B•R•A•H•M•S PCT Becomes the First FDA-cleared Procalcitonin Assay as an Aid for Antibiotic Stewardship in Respiratory Infections and Sepsis". 2017-02-24
Ipsen S.A.. (2/23/17). "Press Release: Ipsen Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017". Paris. 2017-02-23
Valneva S.E.. (2/23/17). "Press Release: Valneva Reports Strong Q4 and FY 2016 Business Performance, Expects Further Growth in Sales and EBITDA, R&D Progress in 2017". Lyon. 2017-02-23
TxCell S.A.. (2/22/17). "Press Release: TxCell Successfully Completes a €11 Million Capital Increase [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan]". Valbonne. 2017-02-22
Neovacs S.A.. (2/21/17). "Press Release: Neovacs and BioSense Sign Option Agreement Worth up to €65 Million plus Royalties for Chinese Development and Commercial Rights to IFNalpha Kinoid for Lupus and Dermatomyositis". Paris. 2017-02-21
Sartorius Stedim Biotech S.A.. (2/21/17). "Press Release: Resolutions by the Board of Directors". Aubagne. 2017-02-21
Biophytis S.A.. (2/21/17). "Press Release: Biophytis Relocates to Pierre and Marie Curie University (UPMC) Campus and Solidifies Creation of Leading Translational Platform for Age-related Disease". Paris. 2017-02-21
Lysogene S.A.. (2/21/17). "Press Release: Lysogene Receives Orphan Drug Designation from EMA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. 2017-02-21
Cerenis Therapeutics S.A.. (2/17/16). "Press Release: 2016 Annual Results. Solid Cash Position of €24.7 million and Finalization of CARAT Phase 2 Clinical Study". Toulouse & Ann Arbor, MI. 2017-02-17
Euronext N.V.. (2/15/17). "Press Release: Inventiva Lists on Euronext Paris. €48 Million Raised, Market Capitalisation €133 Million". Paris. 2017-02-15
Servier. (2/14/17). "Press Release: Servier and GAIA Extend Their Partnership to Provide Patients around the World with Deprexis, an Internet-based Cognitive Behavioral Therapy for Depression". Suresnes & Hamburg. 2017-02-14
Immunicum AB. (2/14/17). "Press Release: Immunicum AB Announces Approval in France for Its Clinical Trial Application for Intuvax in Metastatic Renal Cell Carcinoma". Gothenburg. 2017-02-14
Premaitha Health plc. (2/13/17). "Press Release: New Partnership with Major European Diagnostics Group". Manchester. 2017-02-13
Ipsen S.A.. (2/13/17). "Press Release: Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi". Paris. 2017-02-13
Nicox S.A.. (2/9/17). "Press Release: Nicox to Present at the 6th Annual Leerink Partners Global Healthcare Conference". Sophia Antipolis. 2017-02-09
Neovacs S.A.. (2/9/17). "Press Release: Neovacs Issued New Broad Patent in China for IFNalpha Kinoid". Paris. 2017-02-09
Euronext N.V.. (2/8/17). "Press Release: Lysogene Lists on Euronext. €22.6 Million Raised, Market Capitalisation of approximately €82 Million". Paris. 2017-02-08
Global Bioenergies S.A.. (2/7/17). "Press Release: First Production in History of Fully Renewable ETBE". Évry. 2017-02-07
Pharnext S.A.. (2/7/17). "Press Release: Pharnext to Present at 2017 BIO CEO & Investor Conference". Paris. 2017-02-07
OSE Immunotherapeutics S.A.. (2/7/17). "Press Release: OSE Immunotherapeutics to Present Corporate Overview at Upcoming BIO CEO & Investor Conference New York February 13-14, 2017". Nantes. 2017-02-07
Lysogene S.A.. (2/7/17). "Press Release: Lysogene Announces Its Successful IPO on Euronext Paris with nearly €22.6m Raised [Not for US, CA, AU, JP]". Paris. 2017-02-07
IntegraGen S.A.. (2/3/17). "Press Release: IntegraGen Announces Successful Completion of a € 3.7 Million Capital Increase". Évry. 2017-02-03
Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris. 2017-02-03
Lysogene S.A.. (2/2/17). "Press Release: Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris. 2017-02-02
Ipsen S.A.. (1/31/17). "Press Release: Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma". Paris. 2017-01-31
ElsaLys Biotech S.A.S.. (1/30/17). "Press Release: ElsaLys Biotech Expands Its Team to Strengthen Its Strategy and the Development of Its Programs". Lyon. 2017-01-30
Sanofi S.A.. (1/30/17). "Press Release: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs". Paris. 2017-01-30
Recordati Industria Chimica e Farmaceutica S.p.A.. (1/27/17). "Press Release: Recordati Announces Marketing Approval for Cystadrops". Milan. 2017-01-27
Sensorion S.A.. (1/25/17). "Press Release: Sensorion to Receive €950,000 from Bpifrance and the Occitania Region". Montpellier. 2017-01-25
Lysogene S.A.. (1/25/17). "Press Release: Lysogene Launches Its IPO on Euronext’s Regulated Market in Paris". 2017-01-25
Neovacs S.A.. (1/25/17). "Press Release: Neovacs Reports First Positive Immunogenicity Results for IFN alpha Kinoid in Model of Type 1 Diabetes". Paris & Boston, MA. 2017-01-25
TxCell S.A.. (1/25/17). "Press Release: Txcell Launches a Capital Increase of around 11 Million Euros with Shareholders’ Preferential Subscription Rights [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan] 2017-01-25
DNA Script. (1/23/17). "Press Release: DNA Script Adds Dr. Heiner Dreismann, Former CEO of Roche Molecular Diagnostics, to Board of Directors". Paris. 2017-01-23
Domain Therapeutics S.A.. (1/23/17). "Press Release: Domain Therapeutics and Merck Enter into a License and Collaboration Agreement for Development of Adenosine Receptor Antagonists in Immuno-oncology". Strasbourg. 2017-01-23
bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile. 2017-01-19
bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA. 2017-01-19
Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. 2017-01-18
Sanofi S.A.. (1/18/17). "Press Release: Suliqua Approved in the European Union for the Treatment of Adults with Type 2 Diabetes". Paris. 2017-01-18
McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. 2017-01-09
Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris. 2017-01-09
IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry. 2017-01-09
Abivax S.A.. (1/9/17). "Press Release: Abivax to Receive €8.4 Million from Bpifrance “Invest in the Future Program” (PIA) for the Development of Innovative Antiviral Drugs". Paris. 2017-01-09
McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris. 2017-01-06
Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY. 2017-01-05
Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. 2017-01-05
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top